Health Condition 1: V029- Pedestrian injured in collision with two- or three-wheeled motor vehicle, unspecified whether traffic or nontraffic accident
Conditions
Interventions
Intervention1: Intrathecal Levobupivacaine Plus Nalbuphine: The dose of Nalbuphine is 1 mg, as a adjuvant to Levobupivacaine via spinal anesthesia, the duration of analgesic property is seen and vas s
Sponsors
Government of Gujarat
Eligibility
Inclusion criteria
Inclusion criteria: Asa physical Status 1 and 2
Exclusion criteria
Exclusion criteria: Patient Refusal History of adverse drug reaction Presence of spinal abnormality pr infection History of drug and alcohol abuse Asa physical status III, IV and V Mentally retarded patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to assess and compare the characteristics of sensory and motor blockade by produced by intrathecal hypoerbaric levobubivacaine when combined with nalbuphine and fentanylTimepoint: 30min,1 hour,3 hour,6 hour,12 hours,18 hours,24 hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| sensory & motor blocking properties of nalbuphine & fentanyl are compared & duration is measured through VAS ScoreTimepoint: 30min,1hour,3hour,6hour,12hour,18 hour,24 hour | — |
Countries
India
Contacts
Public ContactDilipsinh Chauhan
B.J.Medical College,Ahmedabad
Outcome results
None listed